ARCHIVES

FDA Revokes Avastin’s Accelerated Approval In Metastatic Breast Cancer Indication

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

DCT Board to Study Modifications Of Existing Cooperative Group System

June 13, 1986

Motesanib Does Not Improve OS; Study Doesn’t Meet Primary Endpoint

April 29, 2011

NCI Cancer Bulletin publicized board’s resignation over liability concerns.

April 16, 2004

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

January 17, 2014

CCRU-CCSP Report At Closed Session “Declassified” Discusses Review

December 3, 1982